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Covalent attachment of sumo to proteins regulates multiple processes in the eukaryotic 
cell. This reaction is similar to ubiquitination and usually requires an E3 ligase for 
substrate modification. However, only a few sumo ligases have been described to date, 
which frequently facilitate sumoylation by bringing together the sumo-conjugating 
enzyme Ubc9 and the target protein. Ubc9 is an interaction partner of the transcription 
factor Krox20, a key regulator of hindbrain development. Here, we show that Krox20 
acts as a sumo ligase for its coregulators -the Nab proteins- and that Nab sumoylation 
negatively modulates Krox20 transcriptional activity in vivo. 
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INTRODUCTION 
Sumoylation consists in the post-translational modification of proteins by the small 
ubiquitin-like modifier (sumo), and regulates many processes in the eukaryotic cell 
(Gareau and Lima, 2010). Sumo is a 100-amino acids polypeptide that is covalently 
attached to the ε-amino group of a Lys residue of target proteins, commonly included in 
the consensus ΨKxE/D (Ψ: large hydrophobic residue). Reaction, similar to 
ubiquitination, involves transfer from the conjugating enzyme Ubc9 to the target protein 
and frequently requires the concourse of a sumo ligase. They often facilitate transfer by 
simultaneously binding Ubc9 and target protein. In comparison with ubiquitination, 
very few sumo ligases have been described so far (Gareau and Lima, 2010). Indeed, 
identification of new sumo ligases still remains an open challenge, and will shed light 
on the mechanisms and regulation of the sumoylation process. 
From a previous two-hybrid screening we identified the sumo-conjugating 
enzyme Ubc9 as a partner of the transcription factor Krox20 (Garcia-Dominguez et al, 
2006), a key regulator of hindbrain development (Schneider-Maunoury et al, 1993), 
where it participates in the control of the expression of a variety of genes, including its 
own and genes encoding its coregulators Nab and the tyrosine kinase receptor EphA4 
(Desmazieres et al, 2009). Development of the vertebrate hindbrain involves a transient 
segmentation process that generates 7 to 8 segments or rhombomeres (r) along the 
anterior-posterior axis (Lumsden and Krumlauf, 1996). Krox20 is expressed in r3 and r5 
and is required for the formation and maintenance of these segments (Schneider-
Maunoury et al, 1993; Voiculescu et al, 2001). Besides three zinc fingers for DNA 
binding, Krox20 contains the R1 motif, the surface for interaction with Nab1 and Nab2, 
initially identified as corepressors (Russo et al, 1995; Svaren et al, 1996). It has been 
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reported that the repressive activity of Nab2 is due in part to interaction with CHD4 
(Srinivasan et al, 2006). 
In this report we show that Krox20 functions as a ligase for the sumoylation of 
its coregulators, the Nab proteins. Sumo modification of Nab2 negatively modulates 
Krox20 transcriptional activity. Thus, sumoylation adds to the list of mechanisms 
involved in Krox20 autoregulation. 
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RESULTS 
Krox20 interacts with Ubc9 
From a previous two-hybrid screening based on Krox20 (Garcia-Dominguez et al, 
2006) we isolated 7 clones corresponding to the sumo-conjugating enzyme Ubc9 (Fig 
1A). Pull-down experiments with purified GST or a GST-Ubc9 fusion, and in vitro 
translated Krox20, demonstrated direct and specific interaction between Krox20 and 
Ubc9 (Fig 1B). We mapped the interaction surface in Krox20 by yeast two-hybrid. 
Analysis indicated that the zinc finger domain was necessary and sufficient for Ubc9 
binding (Fig 1C). 
 
Krox20 acts as a sumo ligase 
Protein interaction with Ubc9 often leads to sumoylation of the interacting protein. 
However, we have previously reported that Krox20 is not sumoylated (Garcia-
Dominguez et al, 2006). Ubc9 also interacts with sumo ligases to facilitate sumoylation 
of target proteins. We therefore speculated that Krox20 might recruit Ubc9 to function 
as a ligase in the sumoylation of other proteins, and the Krox20 coregulators Nab1 and 
Nab2 (Russo et al, 1995; Svaren et al, 1996) represent good candidates. Indeed amino 
acid sequence analysis revealed two conserved sumoylation consensus sites in each 
protein. A two-hybrid assay did not reveal direct interaction between Nab2 and Ubc9 
(not shown). 
To test sumoylation of Nab proteins we performed sumoylation assays in 293T 
cells transfected with flag-tagged Nab expression constructs and analyzed the cell 
extracts by Western blot. Transfection of Nab2 resulted in detection of a single band. 
However, when Nab2 and Krox20 expression vectors were cotransfected, up to 3 
additional bands were observed, consistent with the presence of two sumoylation 
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consensus sites (Fig 2A). Nab1 was also sumoylated in the presence of Krox20 
(supplementary Fig S1A online). Since Nab1 and Nab2 are highly homologous and 
have been shown to display similar functions (Svaren et al, 1996), we restricted the 
following experiments to Nab2, referred to as Nab. In the cell, sumo1 is mostly bound 
to proteins, resulting in a reduced free sumo1 pool (Gareau and Lima, 2010). The 
addition of low amounts of a histidin-tagged sumo1 (His-sumo1) expression vector in 
cotransfections resulted in increased modification of Nab (Fig 2A). Overexpression of 
the different PIAS proteins did not significantly modify sumoylation (data not shown). 
GFP-sumo1 was also efficiently conjugated to Nab (Fig 2B), but not His-sumo2 
(supplementary Fig S1B online). In addition, Nab sumoylation was prevented by a 
dominant negative version of Ubc9 (C93S) (Fig 2C). Nab was specifically modified in 
the presence of Krox20 since a non-related transcription factor (neuroM) had no effects 
(Fig 2C). As expected, double mutant of putative target Lys (K379RK517R (KR2)) was 
not sumo-modified by Krox20 (Fig 2D). The mutation did not affect Nab nuclear 
localization nor its interaction with Krox20 (supplementary Fig S2 online).  
We next investigated the involvement of Krox20-Nab interaction in Nab 
sumoylation. The single mutation I268F in Krox20 and the double mutation 
Q64RH95Q in Nab have been shown to abrogate Krox20-Nab interaction (Svaren et al, 
1998). We found that both mutations prevented sumoylation (Fig 2E). In contrast, 
neither Krox20 nor the I268F mutant showed any effect in general sumoylation as 
monitored by modification of the C-terminal part of RanGAP1 (RanGAP1-C-ter), as a 
control (Fig 2F).  
To investigate sumoylation of endogenous Nab we used P19 cells, as they 
express Krox20 and Nab. In this line, constitutive levels of Nab protein were detected 
under normal growth conditions, whereas Krox20 expression required serum 
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stimulation (Fig 2G and supplementary Fig S3 online). We were not able to observe 
sumoylation of endogenous Nab with endogenous sumo1. Then, we decided to transfect 
P19 cells with low amounts of the His-sumo1 expression vector to analyze Nab 
sumoylation after pull-down of the His-tagged products. As shown in Fig 2G, whereas 
Nab sumoylated forms could not be detected in the input (1.5% of the total), they were 
observed in the precipitates. Moreover, the presence of these bands was strongly 
reinforced upon serum stimulation, i.e. upon induction of Krox20 (Fig 2G). 
Sumoylation of endogenous Nab was also observed upon transfection of a Krox20 
expression vector without serum stimulation (Fig 2H). Finally, knock-down of induced 
Krox20 by a combination of two siRNA molecules also prevented sumoylation of 
endogenous Nab (Fig 2I). 
To definitively demonstrate that Krox20 acts as a sumo ligase for Nab, we 
performed in vitro sumoylation assays with purified proteins produced in bacteria. As 
illustrated in Fig 2J, sumoylation of Nab occurred in vitro and was indeed dependent on 
the presence of Krox20. Furthermore, comparison of the number of molecules between 
input Krox20 (0.3 10-12 mol) and sumoylated Nab (2.78 10-12 mol, as estimated by 
measure of chemiluminescence from western blots and comparing to the amount of 
loaded protein, Fig 2J) indicated a much larger number of sumoylated Nab molecules, 
suggesting that Krox20 was acting in a catalytic manner. 
 
Nab sumoylation contributes to recruit sumo to chromatin 
We next investigated whether sumo can be recruited to a Nab-regulated sequence in the 
context of chromatin. We chose to examine the Id4 promoter because it has been 
previously shown to be regulated by the Krox20-Nab complex (Mager et al, 2008). In 
P19 cells, serum addition led to a 3-fold increase in sumo levels associated to the Id4 
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promoter (Fig 3A). To investigate whether Nab sumoylation was involved, cells were 
transfected with wild type Nab or the KR2 mutant immediately after serum deprivation. 
Whereas in the presence of wild type Nab the increase of sumo levels were similar to 
those observed in the absence of transfection, with the KR2 mutant serum-mediated 
accumulation of sumo on the Id4 promoter was impaired, presumably due to 
competition with the endogenous Nab (Fig 3A). 
 
Nab sumoylation modulates Krox20 activity in vivo 
To evaluate whether Nab sumoylation has an impact on Krox20 transcriptional control, 
we took advantage of a lacZ-based reporter of Krox20 activity (Garcia-Dominguez et 
al, 2006). This construct was transfected in P19 cells together with Krox20, sumo1 and 
Nab expression constructs. The analysis demonstrated that Nab efficiently repressed 
Krox20 transcriptional activity in the presence of sumo, whereas the KR2 mutant 
resulted in increased reporter activity, suggesting a dominant negative effect (Fig 3B). 
 To investigate the possible modulation of Krox20 activity by Nab sumoylation 
in vivo, we turned to the hindbrain, where Krox20 regulates a variety of genes, 
including itself and Nab genes, in r3 and r5 (Desmazieres et al, 2009; Mechta-Grigoriou 
et al, 2000; Chomette et al, 2006; Giudicelli et al, 2001). Furthermore, in gain-of-
function experiments, Nab was shown to repress Krox20 activity, suggesting the 
existence of a negative feedback regulatory loop (Mechta-Grigoriou et al, 2000).  
Electroporation of chick embryos allows gain-of-function analysis in the 
hindbrain. We first confirmed the expression of Ubc9 in this structure by in situ 
hybridization and immunofluorescence analyses (Fig 4A,B). We analyzed the 
consequences of Nab and sumo misexpression on the expression of the r3/r5 marker 
EphA4, whose gene is under direct control of Krox20 (Theil et al, 1998). Since 
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electroporation only affects one side, the other constitutes a control. Limited repression 
of EphA4 upon electroporation of Nab expression vectors has been previously reported 
(Desmazieres et al, 2009) and was confirmed in our experiments (Fig 4C,D,K). We 
observed that coelectroporation with Nab and sumo expression vectors led to more 
severe repression (Fig 4C-H,K). In contrast, electroporation of the KR2 mutant led to 
upregulation of EphA4 (Fig 4I-K). Analysis of the expression of the r4 marker Hoxb1 
together with EphA4 by double in situ hybridization showed that electroporation of Nab 
KR2 also resulted in reduced r4 size (Fig 4L,N), possibly associated with r3 and/or r5 
expansion. Finally, expression of Krox20 itself appeared upregulated upon KR2 
electroporation, similar to EphA4 (Fig 4M,N). Together these data support an 
involvement of Nab sumoylation in the repression of Krox20 activity in the hindbrain. 
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DISCUSSION 
In this work we report that Krox20 acts as a ligase in the sumoylation reaction of its 
coregulators, the Nab proteins. Ligase activity of Krox20 is based on the following 
observations: i) over-expression of Krox20 under limiting sumo availability leads to 
sumoylation of transfected Nab; ii) Krox20 is able to recruit Ubc9 and Nab through 
different domains; iii) physical interaction between ligase and target is critical for 
modification; iv) sumoylation of endogenous Nab can also be observed in cultured cells 
and is dependent on Krox20 expression; v) Krox20 promotes Nab sumoylation in vitro 
and acts in a catalytic manner. To our knowledge, this constitutes the first example of a 
transcription factor acting as a ligase for the sumoylation of its own coregulators. Our 
results support a role of Krox20 in locally recruiting Ubc9 for sumoylation of other 
components in its transcriptional complex, the Nab proteins, contributing to explain 
how specificity of target sumoylation may be achieved. This raises the possibility that 
other factors might be sumoylated using Krox20 as a ligase, an exciting hypothesis 
considering the role of Krox20 in various developmental systems (Schneider-Maunoury 
et al, 1993; Topilko et al, 1994). Our findings also represent a stimulus for the 
identification of new ligases. Different types of ligase do not share significant 
homology. Similarly, no significant homology was observed between Krox20 and 
previously described ligases. These have in common the ability to interact with Ubc9, in 
many cases through apparently unrelated domains. The zinc finger domain of Krox20 
binds Ubc9. Intriguingly, different zinc-based structures have been reported to be 
involved in Ubc9 binding and ligase function (Garcia-Dominguez et al, 2008). 
Several pieces of evidence are consistent with a role of Nab sumoylation in vivo: 
i) Nab sumoylation modulates Krox20 transcriptional activity in a reporter assay in 
cultured cells; ii) sumo recruitment to the Id4 promoter is dependent on Nab 
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sumoylation sites; iii) altered Nab sumoylation affects the expression of Krox20 target 
genes in the hindbrain. Despite the numerous roles attributed to sumo in eukaryotic 
cells, a function in transcriptional repression stands out (Garcia-Dominguez and Reyes, 
2009). Accordingly, our results support a role of Nab sumoylation in transcriptional 
repression. Srinivasan and collaborators have reported that CHD4 participates in but 
does not account for full repression activity associated to Nab2 (Srinivasan et al, 2006), 
supporting the involvement of additional mechanisms, for instance sumoylation. Indeed, 
the fact that both wild type Nab and the KR2 mutant equally interact with CHD4 
(supplementary Fig S1C online) suggests that sumoylation is not involved in CHD4 
recruitment. 
It has been proposed that Krox20 mediates expansion of r3 and r5 territories by 
recruiting cells from adjacent even-numbered territories (Giudicelli et al, 2001). 
Subsequently, other mechanisms should limit Krox20 activity to restrict expansion of r3 
and r5. Induction by Krox20 of its own corepressors, the Nab proteins, has been 
proposed as one of these mechanisms (Mechta-Grigoriou et al, 2000). In agreement 
with this hypothesis, interference with the interaction between Krox20 and Nab proteins 
leads to delayed downregulation of Krox20 target genes (Desmazieres et al, 2009; 
Desmazieres et al, 2008). In this report we show that interfering with Nab sumoylation 
also leads to altered expression of Krox20 target genes and to modifications in the size 
of rhombomeres. Together, our data are consistent with Nab sumoylation limiting 
Krox20 activity and the extension of Krox20-positive territories, in agreement with the 
proposed role of Nab proteins. However, experiments performed in the mouse have 
shown that double Nab knock-out or knock-in of the I268F mutation in Krox20 do not 
lead to major defects in hindbrain patterning (Desmazieres et al, 2008; Le et al, 2005). 
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This suggests the existence of redundant mechanisms for the limitation of the expansion 
of Krox20-positive territories. 
In conclusion, we have revealed an intriguing novel activity of the Krox20 
transcription factor, as a sumo ligase for its coregulators Nab. Nab sumoylation affects 
Krox20 transcriptional activity, establishing an additional loop in the complex control 
of its own activity and expression by Krox20. 
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METHODS 
Plasmid constructs, protein production and purification, yeast two-hybrid and 
pull-down assays. Details for plasmid constructs and protein production and 
purification are provided as supplementary information online. Yeast two-hybrid was 
previously described (Garcia-Dominguez et al, 2006). Pull-down experiments were 
carried out with GST or GST-Ubc9 proteins loaded on Glutathione Sepharose 4B beads 
(GE, Healthcare) and in vitro translated Krox20, as previously described (Garcia-
Dominguez et al, 2006), or from 2 107 His-sumo1 transfected cells under denaturating 
conditions (6 M urea) using His-Select Nickel Affinity Gel (Sigma) as indicated by 
manufacturer. 
Cell culture, transfection, reporter and sumoylation assays and Western blot. 293T 
and P19 cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 
7% fetal bovine serum and α-modified Eagle’s medium supplemented with 7.5% calf 
and 2.5% fetal bovine sera (PAA), respectively. For serum stimulation, P19 cells were 
deprived of serum for 48 h and harvested 2 h after serum re-addition. Transient 
transfections of plasmids or siRNA molecules were performed with Lipofectamine 2000 
or Oligofectamine (Invitrogen), 36 or 48 h before harvesting the cells, respectively. The 
sequences of the siRNAs are provided in supplementary Table S1 online. For 
sumoylation assays in cells, we used 0.5 µg of RSV-flag-Nab2, 0.15 µg of RSV-His-
sumo1/2 and 1 µg of other constructs. ß-galactosidase activity of reporter construction 
was determined using a chemiluminescent assay (Roche). The CMV-driven luciferase 
expression vector pGL4.51 (Promega) was used for normalization. For Western blot, 
cell extracts were prepared in 8 M urea, 10 mM Tris-HCl pH8.0, and analyzed with the 
ECL procedure (GE Healthcare). A ChemiDocXRS apparatus (Bio-Rad) was used for 
 14 
chemiluminescence measurement. Antibodies and in vitro sumoylation assay are 
detailed in supplementary information online. 
Chromatin immunoprecipitation and quantitative PCR. Chromatin 
immunoprecipitation (ChIP) experiments were performed on P19 cells. 107 cells fixed 
in 1% formaldehyde for 10 min at 37 ºC were used in each experiment. The D-11 anti-
sumo1 antibody (sc-5308, Santa Cruz Biotechnology) was used for chromatin 
precipitation. Quantitative PCR was used for analysis of the Id4 promoter and 
determination of gene expression levels, as detailed in supplementary information 
online. Sequence of primers is provided in supplementary Table S1 online. 
In ovo electroporation, immunofluorescence and in situ hybridization. 
Electroporation, preparation of embryos for immunofluorescence and in situ 
hybridization were conducted as previously described (Giudicelli et al, 2001). Eggs 
were incubated at 38 ºC for 30 h (stage HH8-HH9) for electroporation and embryos 
were recovered 24 h after. For electroporation monitoring, the GFP expression vector 
pEGFP-N1 (Clontech) was used at 0.3 µg/µl. Other constructs were electroporated at 1 
µg/µl. Protocols for immunofluorescence and in situ hybridization have been previously 
described (Garcia-Dominguez et al, 2006). Probes and antibodies are detailed in 
supplementary information on line. Fluorescent images were acquired on a Leica 
confocal microscope. 
Supplementary information is available at EMBO reports online. 
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FIGURE LEGENDS 
Fig 1. The zinc finger domain of Krox20 mediates interaction with Ubc9. (A) Growth 
of yeast transformed with the indicated constructs was tested on non-selective and 
selective media. Bait and prey constructs were based on Gal4 DNA binding domain 
(G4DB) and Gal4 activation domain (G4AD) vectors, respectively. (B) Pull-down 
experiments were carried out with immobilized purified GST or GST-Ubc9 fusion and 
in vitro translated radioactively labeled Krox20. (C) Deletion constructs of Krox20 were 
tested for interaction with Ubc9 by yeast two-hybrid as indicated in (A). 
Fig. 2. Krox20 mediates Nab sumoylation.  (A-F) 293T cells were transfected with flag-
Nab or flag-RanGAP1-C-ter (flag-Ran) expression vectors and the constructs indicated 
at the top of each panel. Flag-tagged proteins were detected by Western blot. Black 
arrowheads indicate non-modified proteins and other arrowheads indicate modified 
proteins. Bottom panels correspond to inputs of the indicated proteins. (A,B) Nab is 
sumoylated in the presence of Krox20 and sumoylation is enhanced if low amounts of 
His-sumo1 or GFP-sumo1 are transfected. (C) Nab is specifically sumoylated by 
Krox20, as the addition of neuroM does not affect Nab sumoylation state; however, 
dominant negative Ubc9 (C93S) interferes with Nab sumoylation. (D) The Nab 
K379RK517R (KR2) protein is not sumoylated. (E) Krox20 I268F and Nab Q64RH95Q 
mutants, affected in their ability to interact with each other, are ineffective as ligase and 
target in the sumoylation reaction, respectively. (F) Sumoylation of RanGAP1-C-ter is 
not altered by the presence of Krox20 or the I268F mutant. (G-I) Sumoylation of 
endogenous Nab was analyzed in P19 cells in pull-down experiments with anti-Nab 
antibodies. (G) Endogenous Nab is sumoylated following His-sumo1 transfection and 
serum stimulation, which results in the expression of Krox20. (H) Sumoylation of 
endogenous Nab was also observed upon transfection of an HA-Krox20 expression 
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construct under normal growth conditions (H). Nab sumoylation was prevented by 
transfection of Krox20 siRNA (si), and not by a control GFP siRNA, under serum 
stimulation conditions (I). Upper panel in (G-I) shows pulled His-sumo1-Nab, revealed 
with anti-Nab antibodies, while lower panels show 1.5% input of the indicated proteins. 
Note that anti-Krox20 antibodies also reveal a non-specific upper band. (J) In vitro 
sumoylation assays with 300 ng of purified flag-tagged Nab were carried out in the 
presence or the absence of mature sumo (sumo1GG) and 15 ng of Krox20 as indicated. 
Sumoylated products corresponded to 52,96% ± 2,74 (mean ± s.d.) of loaded protein, as 
determined by chemiluminescence measurement from 3 independent western blots. 
Fig. 3. Sumoylation of Nab contributes to sumo recruitment to chromatin and modulates 
Krox20 transcriptional activity. (A) Sumo levels associated to the Id4 promoter were 
determined by ChIP experiments in P19 cells transfected with flag-tagged wild type 
Nab or the KR2 mutant or not transfected (-). Sumo levels were determined on cells 
normally growing (white bars) or subjected to serum stimulation (black bars). Fold-
increase in sumo levels were normalized to the value determined in non-transfected 
untreated cells. Flag levels were also determined as a control (grey bars) and fold-
increase was normalized to the value of Nab transfected cells. (B) A lacZ reporter 
construct responsive to Krox20 was tested in P19 cells cotransfected with the indicated 
expression constructs. Relative units of ß-galactosidase were normalized to the value of 
cells cotransfected with Krox20 alone (100%). Values are means of three independent 
experiments ± s.d. 
Fig. 4. Nab sumoylation regulates Krox20 target genes in vivo. Flat mounted chick 
hindbrains were analyzed by in situ hybridization using an Ubc9 antisense RNA probe 
(A) or by immunofluorescence using Ubc9 and EphA4 antibodies (B). (C-J) The neural 
tube of chick embryos was electroporated with constructs expressing the proteins 
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indicated at the top of each panel. GFP was used to monitor electroporation. 
Electroporated hindbrains were processed for immunofluorescence using EphA4 
antibodies (C-J), or in situ hybridization using EphA4, Hoxb1 and Krox20 RNA probes 
(L,M). Arrowheads in (L) delimit r4. Electroporations were performed on the left side 
of embryos. (K) Fluorescence signals of EphA4 hybridization in C, E, G and I were 
measured using the MetaMorph software. For that, regions of the same area 
encompassing rhombomeres 3 to 5 were defined on both electroporated and control 
sides. (N) Size of r4 was determined by measurement of the Hoxb1 positive area using 
the ImageJ application and intensity of the Krox20 hybridization signal was measured 
with the MetaMorph software on inverted grey scale-converted images. Relative levels 
were normalized in respect to those on the control side (-). Values correspond to the 
mean ± s.d. of 5 to 8 samples from three independent experiments. Statistical 
significance was analyzed using the Student’s t-test: (K) *p=0.13, **p<0.025, 









Plasmid	   constructs.	  Deletion	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   Krox20	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   standard	   PCR	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  GFP-­‐sumo1	  were	  derived	  from	  vector	  pAdRSV-­‐Sp	  (RSV)	  (Giudicelli	  et	  al,	  2003),	  with	  flag,	  HA	  or	  
His	  tail	  tags.	  Mouse	  Nab1,	  Nab2,	  Ubc9,	  CHD4,	  Aos1,	  and	  Uba2,	  and	  human	  sumo1	  and	  sumo2	  were	  cloned	  by	  RT-­‐
PCR	  reactions	  with	  RNA	  isolated	  from	  mouse	  P19	  or	  human	  293T	  cells.	  The	  Krox20	  I268F,	  Nab2	  Q64RH95Q	  and	  the	  
Ubc9	  C93S	  mutations,	   and	   the	  HA-­‐neuroM	  expression	   and	  EphA4-­‐lacZ	   reporter	   constructs	   have	  been	  described	  
elsewhere	  (Garcia-­‐Dominguez	  et	  al,	  2006;	  Garcia-­‐Dominguez	  et	  al,	  2003;	  Giorgino	  et	  al,	  2000;	  Svaren	  et	  al,	  1998).	  
The	  RanGAP1-­‐C-­‐ter	  expression	  construct,	  corresponding	  to	  the	  C	  terminus	  of	  RanGAP1,	  was	  derived	  from	  plasmid	  
pET28RanGAP1-­‐C2	  (Uchimura	  et	  al,	  2004),	  and	  was	  used	  as	  a	  control	  for	  sumoylation	  (Lee	  et	  al,	  1998).	  Mutation	  of	  
Lys379	   and	   Lys517	   of	   Nab2	   to	   Arg	  was	   conducted	   by	   standard	   PCR	   techniques.	   The	   GFP-­‐sumo1	   construct	   was	  
based	   on	   the	   pEGFP-­‐C2	   plasmid	   (Clontech).	   GST	   constructions	   were	   derived	   from	   plasmid	   pGEX-­‐6P-­‐3	   (GE	  
Healthcare).	  The	  pET28a	  plasmid	  (Novagen)	  was	  used	  for	  bacterial	  production	  of	  Nab2.	  
Protein	  purification	  and	   in	  vitro	  sumoylation	  assay.	  Mouse	  Krox20,	  Ubc9,	  Aos1	  and	  Uba2,	  and	  matured	  human	  
sumo1,	  were	  produced	  in	  E.	  coli	  DH5α	  at	  20	  °C	  as	  GST	  fusions	  and	  purified	  with	  Glutathione	  Sepharose	  4B	  beads	  
(GE,	  Healthcare)	  as	  indicated	  by	  manufacturer.	  Except	  for	  Aos1	  and	  Uba2,	  the	  GST	  moiety	  was	  excised	  by	  using	  the	  
PreScission	  protease	  (GE,	  Healthcare).	  His	  and	  flag-­‐tagged	  mouse	  Nab2	  was	  produced	  in	  E.	  coli	  BL21(DE3)	  at	  4	  °C	  
and	  purified	  with	  His-­‐Select	  Nickel	  Affinity	  Gel	  (Sigma)	  as	   indicated	  by	  manufacturer.	   In	  vitro	  sumoylation	  assays	  
with	  purified	  Nab2	  and	  Krox20	  were	  performed	  at	  30	  °C	  for	  2	  h	  in	  20	  µl	  of	  20	  mM	  Hepes	  pH	  7.5,	  50	  mM	  NaCl,	  4	  
mM	  MgCl2	  and	  1	  mM	  DTT	  buffer,	  containing	  0.2	  µg	  of	  Aos1/Uba2	  mix	  (E1),	  0.25	  µg	  of	  Ubc9	  and	  1	  µg	  of	  sumo1.	  
Reactions	   were	   initiated	   with	   250	   µM	   ATP	   and	   stopped	   with	   SDS	   and	   ß-­‐mercaptoethanol-­‐containing	   Laemmli	  
buffer.	  
Western	  blot.	  Antibodies	  and	  dilutions	  were	  as	  follows:	  mouse	  monoclonal	  anti-­‐flag	  M2	  (Sigma-­‐Aldrich,	  1:2000),	  
rat	  monoclonal	  anti-­‐HA	  (Roche,	  1:2000),	  rabbit	  anti-­‐Krox20	  (Covance,	  1:1000),	  mouse	  anti-­‐Nab2	  1C4	  (Santa	  Cruz	  
Biotecgnology	  sc-­‐23867,	  1:1000),	  goat	  anti-­‐mouse	  HRP,	  anti-­‐rat	  HRP	  and	  anti-­‐rabbit	  HRP	  (Sigma-­‐Aldrich,	  1:10,000).	  
Quantitative	   PCR.	   For	   gene	   expression	   analysis	   total	   RNA	   was	   isolated	   with	   the	   RNAsy	   kit	   (QIAGEN).	   For	  
retrotranscription	  of	  RNA	  we	  used	  the	  Superscript	  III	  enzyme	  (Invitrogen).	  Quantitative	  PCR	  reactions,	  in	  triplicate,	  
were	  performed	  with	   the	  SensiMix	  SYBR	  Low-­‐ROX	  kit	   (BIOLINE)	   in	   the	  Applied	  Biosystems	  7500	  FAST	  Real-­‐Time	  
PCR	  System.	  GAPDH	  was	  used	   for	  normalization.	  Primers	   for	  gene	  expression	  analysis	  and	  ChIP	  are	  described	   in	  
Table	   S1.	   Algorisms	   for	   calculation	   of	   relative	   units	   and	   normalization	   of	   values	   according	   to	   oligonucleotide	  
efficiencies	  are	  described	  in	  (Pfaffl,	  2001).	  
Immunofluorescence	  and	   in	  situ	  hybridization.	  Antibodies	  and	  dilutions	  were	  as	  follows:	  rabbit	  anti-­‐EphA4	  S-­‐20	  
(sc-­‐921,	  Santa	  Cruz	  biotechnology,	  1:100),	  mouse	  anti-­‐Ubc9	  (BD	  Bioscience,	  1:100),	  donkey	  anti-­‐rabbit	  DyLight549	  
and	   DyLight488,	   and	   donkey	   anti-­‐mouse	   DyLight649	   (Jackson	   ImmunoResearch,	   1:800).	   Full-­‐length	   Ubc9	   was	  
cloned	  in	  pBluescript	  SK+	  for	  synthesis	  of	  antisense	  RNA	  probe.	  cDNA	  was	  obtained	  by	  PCR	  with	  primers	  based	  on	  
available	  EST	   sequences.	  Other	  probes	  were	  previously	  described:	  Krox20	   (Giudicelli	   et	  al,	   2001),	  EphA4	   (Sajjadi	  










	  	  	  	  	  
	  
Fig	  S1.	  Analysis	  of	  Nab	  sumoylation.	  293T	  cells	  were	  transfected	  with	  flag-­‐Nab1	  (A)	  or	  flag-­‐Nab2	  (B)	  and	  the	  constructs	  indicated	  at	  the	  top	  of	  
each	  panel.	   Flag-­‐tagged	  proteins	  were	  detected	  by	  Western	  blot.	   Black	   arrowheads	   indicate	   non-­‐modified	  proteins	  while	   open	   arrowheads	  
indicate	  modified	  proteins.	  Nab1	  was	  sumoylated	  in	  293T	  cells	  (A).	  Nab2	  was	  more	  efficiently	  sumoylated	  by	  sumo1	  than	  by	  sumo2	  (B).	  (C)	  To	  
test	  interaction	  of	  Nab	  and	  the	  KR2	  mutant	  with	  CHD4,	  293T	  cells	  were	  transfected	  with	  expression	  constructs	  of	  these	  molecules	  as	  indicated.	  
For	   CHD4	   we	   expressed	   the	   Nab-­‐interacting	   domain	   tagged	   to	   the	   HA	   epitope	   (Srinivasan	   et	   al,	   2006).	   Cell	   extracts	   were	   subjected	   to	  
immunoprecipitation	  experiments	  with	  anti-­‐flag	  antibodies	  and	  precipitates	  were	  analyzed	  by	  Western	  blot	  with	  anti-­‐HA	  antibodies.	  10%	  of	  
input	  proteins	  are	  also	  shown.	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Fig	  S2.	  The	  KR2	  mutant	  localizes	  to	  the	  nucleus	  and	  interacts	  with	  Krox20.	  (A)	  293T	  cells	  transfected	  with	  expression	  constructs	  corresponding	  
to	  flag-­‐tagged	  wild	  type	  Nab	  (Fl-­‐Nab)	  and	  the	  KR2	  mutant	  	  were	  analyzed	  by	  immunofluorescence	  using	  an	  anti-­‐flag	  antibody	  (red).	  DNA	  was	  
visualized	  by	  DAPI	  staining	  (blue).	  (B)	  ß-­‐galactosidase	  assays	  were	  used	  to	  analyze	  the	  interaction	  between	  the	  indicated	  proteins	  by	  yeast	  two-­‐
hybrid.	  Bait	  and	  prey	  constructions	  were	  based	  on	  Gal4	  DNA	  binding	  domain	  (G4DB)	  and	  Gal4	  activation	  domain	  (G4AD)	  vectors,	  respectively.	  
Activities	  are	  indicated	  in	  Miller	  units	  and	  correspond	  to	  means	  of	  three	  independent	  experiments	  ±	  s.d.	  
	  
	  
Fig	   S3.	  Expression	   levels	   of	  Nab2	   and	  Krox20	   genes	   in	   P19	   cells.	   Expression	  
levels	   of	   Nab2	   and	   Krox20	   in	   proliferating	   P19	   cells	   (grey	   bars)	   were	  
determined	  by	  quantitative	  PCR	  after	  retrotranscription	  of	  the	   isolated	  RNA.	  
Levels	   of	   well-­‐expressed	   and	   not	   expressed	   genes	   such	   as	   Oct-­‐4	   and	   GFP,	  
respectively,	  were	  determined	   as	   controls.	   Levels	   of	  Nab2	   and	  Krox20	  were	  
also	  measured	  after	  serum	  stimulation	  (black	  bars).	  Means	  of	  arbitrary	  units	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Table	  S1.	  Sequence	  of	  primers	  and	  siRNAs	  
Primer	   Sequence	  
Nab2-­‐F	   AGGAAGAGGAGATCCGGAAG	  
Nab2-­‐R	   GTGTTGTCCCTCATGCAGAA	  
Krox20-­‐F	   CAGGAGTGACGAAAGGAAGC	  
Krox20-­‐R	   GACCAGAGGCTGAAGACTGG	  
GAPDH-­‐F	   AACTTTGGCATTGTGGAAGG	  
GAPDH-­‐R	   GGATGCAGGGATGATGTTCT	  
Id4prom-­‐F	   GCGCGGCTCTACAAATACTGC	  
Id4prom-­‐R	   AACCGCGCCTCCCAGCTCAAC	  
GFP-­‐F	   CAAGATCCGCCACAACATCG	  
GFP-­‐R	   GTCCATGCCGAGAGTGATCC	  
Oct4-­‐F	   CCAATCAGCTTGGGCTAGAG	  
Oct4-­‐R	   CTGGGAAAGGTGTCCCTGTA	  
siRNA	  Krox20#1	   CGCCAAGGCCGUAGACAAA	  
siRNA	  Krox20#2	   GCCCUUCCAGUGUCGGAUC	  
siRNA	  GFP	   GGCACAAGCUGGAGUACAA	  
